Advertisement

Future Directions in Vascularized Composite Allotransplantation Field

  • Yur-Ren Kuo
Chapter
Part of the Head and Neck Cancer Clinics book series (HNCC)

Abstract

Vascularized composite allotransplantation (VCA) was proposed as a feasible treatment option for complex reconstructive procedures, which includes tumor ablation surgeries, traumatic injuries, and burn-induced extensive tissue loss. Composite tissue allotransplantation is composed of heterogeneous tissues of diverse antigenicity, including the skin, fat, lymph nodes, muscle, nerves, ligaments, cartilage, bone, and bone marrow. Therefore, VCA is believed to generate a higher response in comparison with transplant of solid organs (e.g., the heart, lung, kidney, liver, etc.). VCA serves to solve functional loss and improves the quality of life comparing with solid organ transplantation (SOT), which is lifesaving in most circumstances.

References

  1. 1.
    Siemionow MZ, Kulahci Y, Bozkurt M. Composite tissue allotransplantation. Plast Reconstr Surg. 2009;124(6 Suppl):e327–39.CrossRefGoogle Scholar
  2. 2.
    Dubernard JM, Owen E, Herzberg G, Lanzetta M, Martin X, Kapila H, et al. Human hand allograft: report on first 6 months. Lancet. 1999;353(9161):1315–20.CrossRefPubMedGoogle Scholar
  3. 3.
    Dubernard JM, Lengele B, Morelon E, Testelin S, Badet L, Moure C, et al. Outcomes 18 months after the first human partial face transplantation. N Engl J Med. 2007;357(24):2451–60.CrossRefGoogle Scholar
  4. 4.
    Petruzzo P, Dubernard JM. The international registry on hand and composite tissue allotransplantation. Clin Transpl. 2011:247–53.Google Scholar
  5. 5.
    Mohan R, Borsuk DE, Dorafshar AH, Wang HD, Bojovic B, Christy MR, et al. Aesthetic and functional facial transplantation: a classification system and treatment algorithm. Plast Reconstr Surg. 2014;133(2):386–97.CrossRefGoogle Scholar
  6. 6.
    Hartman RG. Face value: challenges of transplant technology. Am J Law Med. 2005;31(1):7–46.CrossRefGoogle Scholar
  7. 7.
    Rohrich RJ, Longaker MT, Cunningham B. On the ethics of composite tissue allotransplantation (facial transplantation). Plast Reconstr Surg. 2006;117(6):2071–3.CrossRefGoogle Scholar
  8. 8.
    Simmons PD. Ethical considerations in composite tissue allotransplantation. Microsurgery. 2000;20(8):458–65.CrossRefGoogle Scholar
  9. 9.
    Hettiaratchy S, Randolph MA, Petit F, Lee WP, Butler PE. Composite tissue allotransplantation—a new era in plastic surgery? Br J Plast Surg. 2004;57(5):381–91.CrossRefGoogle Scholar
  10. 10.
    Lanzetta M, Petruzzo P, Margreiter R, Dubernard JM, Schuind F, Breidenbach W, et al. The international registry on hand and composite tissue transplantation. Transplantation. 2005;79(9):1210–4.CrossRefGoogle Scholar
  11. 11.
    Dunn DL. Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation. Crit Care Clin. 1990;6(4):955–77.CrossRefGoogle Scholar
  12. 12.
    Moore FD. Three ethical revolutions: ancient assumptions remodeled under pressure of transplantation. Transplant Proc. 1988;20(1 Suppl 1):1061–7.Google Scholar
  13. 13.
    Jones JW, Gruber SA, Barker JH, Breidenbach WC. Successful hand transplantation. One-year follow-up. Louisville hand transplant team. N Engl J Med. 2000;343(7):468–73.CrossRefGoogle Scholar
  14. 14.
    Petruzzo P, Badet L, Lanzetta M, Dubernard JM. Concerns on clinical application of composite tissue allotransplantation. Acta Chir Belg. 2004;104(3):266–71.CrossRefGoogle Scholar
  15. 15.
    Petruzzo P, Lanzetta M, Dubernard JM, Landin L, Cavadas P, Margreiter R, et al. The international registry on hand and composite tissue transplantation. Transplantation. 2010;90(12):1590–4.CrossRefGoogle Scholar
  16. 16.
    Siemionow M, Ozturk C. An update on facial transplantation cases performed between 2005 and 2010. Plast Reconstr Surg. 2011;128(6):707e–20e.CrossRefGoogle Scholar
  17. 17.
    Calne RY, Alexandre GP, Murray JE. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann N Y Acad Sci. 1962;99:743–61.CrossRefGoogle Scholar
  18. 18.
    Kaden J, May G, Strobelt V, Groth J, Muller P. Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation. Transplant Proc. 1997;29(1–2):344–7.CrossRefGoogle Scholar
  19. 19.
    Matas AJ, Kandaswamy R, Humar A, Payne WD, Dunn DL, Najarian JS, et al. Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Ann Surg. 2004;240(3):510–6. discussion 6-7CrossRefPubMedGoogle Scholar
  20. 20.
    Shores JT, Imbriglia JE, Lee WP. The current state of hand transplantation. J Hand Surg Am. 2011;36(11):1862–7.CrossRefGoogle Scholar
  21. 21.
    Petit F, Minns AB, Dubernard JM, Hettiaratchy S, Lee WP. Composite tissue allotransplantation and reconstructive surgery: first clinical applications. Ann Surg. 2003;237(1):19–25.CrossRefPubMedGoogle Scholar
  22. 22.
    Ravindra KV, Wu S, McKinney M, Xu H, Ildstad ST. Composite tissue allotransplantation: current challenges. Transplant Proc. 2009;41(9):3519–28.CrossRefGoogle Scholar
  23. 23.
    Ravindra KV, Ildstad ST. Immunosuppressive protocols and immunological challenges related to hand transplantation. Hand Clin. 2011;27(4):467–79. ixCrossRefGoogle Scholar
  24. 24.
    Nankivell BJ, Alexander SI. Rejection of the kidney allograft. N Engl J Med. 2010;363(15):1451–62.CrossRefGoogle Scholar
  25. 25.
    Lee WP, Yaremchuk MJ, Pan YC, Randolph MA, Tan CM, Weiland AJ. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg. 1991;87(3):401–11.CrossRefGoogle Scholar
  26. 26.
    Barker JH, Francois CG, Frank JM, Maldonado C. Composite tissue allotransplantation. Transplantation. 2002;73(5):832–5.CrossRefGoogle Scholar
  27. 27.
    Brouha P, Naidu D, Cunningham M, Furr A, Majzoub R, Grossi FV, et al. Risk acceptance in composite-tissue allotransplantation reconstructive procedures. Microsurgery. 2006;26(3):144–9. discussion 9-50CrossRefGoogle Scholar
  28. 28.
    Gordon CR, Abouhassan W, Avery RK. What is the true significance of donor-related cytomegalovirus transmission in the setting of facial composite tissue allotransplantation? Transplant Proc. 2011;43(9):3516–20.CrossRefGoogle Scholar
  29. 29.
    Siemionow M, Ozturk C. Face transplantation: outcomes, concerns, controversies, and future directions. J Craniofac Surg. 2012;23(1):254–9.CrossRefGoogle Scholar
  30. 30.
    Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008;358(4):353–61.CrossRefPubMedGoogle Scholar
  31. 31.
    Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, et al. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant. 2011;11(7):1464–77.CrossRefPubMedGoogle Scholar
  32. 32.
    Hewitt CW, Ramsamooj R, Patel MP, Yazdi B, Achauer BM, Black KS. Development of stable mixed T cell chimerism and transplantation tolerance without immune modulation in recipients of vascularized bone marrow allografts. Transplantation. 1990;50(5):766–72.CrossRefGoogle Scholar
  33. 33.
    Hettiaratchy S, Melendy E, Randolph MA, Coburn RC, Neville DM Jr, Sachs DH, et al. Tolerance to composite tissue allografts across a major histocompatibility barrier in miniature swine. Transplantation. 2004;77(4):514–21.CrossRefPubMedGoogle Scholar
  34. 34.
    Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003;299(5609):1057–61.CrossRefGoogle Scholar
  35. 35.
    Szajerka T, Klimczak A, Jablecki J. Chimerism in hand transplantation. Ann Transplant. 2011;16(1):83–9.PubMedGoogle Scholar
  36. 36.
    Taylor PA, Lees CJ, Blazar BR. The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002;99(10):3493–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Taylor PA, Friedman TM, Korngold R, Noelle RJ, Blazar BR. Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cell. Blood. 2002;99(12):4601–9.CrossRefGoogle Scholar
  38. 38.
    Eljaafari A, Badet L, Kanitakis J, Ferrand C, Farre A, Petruzzo P, et al. Isolation of regulatory T cells in the skin of a human hand-allograft, up to six years posttransplantation. Transplantation. 2006;82(12):1764–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Morelli AE, Thomson AW. Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev. 2003;196:125–46.CrossRefGoogle Scholar
  40. 40.
    Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol. 2007;7(8):610–21.CrossRefGoogle Scholar
  41. 41.
    Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000;192(9):1213–22.CrossRefPubMedGoogle Scholar
  42. 42.
    Turnquist HR, Raimondi G, Zahorchak AF, Fischer RT, Wang Z, Thomson AW. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol. 2007;178(11):7018–31.CrossRefGoogle Scholar
  43. 43.
    Kuo YR, Goto S, Shih HS, Wang FS, Lin CC, Wang CT, et al. Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model. Transplantation. 2009;87(12):1769–77.CrossRefGoogle Scholar
  44. 44.
    Sacks JM, Kuo YR, Taieb A, Breitinger J, Nguyen VT, Thomson AW, et al. Prolongation of composite tissue allograft survival by immature recipient dendritic cells pulsed with donor antigen and transient low-dose immunosuppression. Plast Reconstr Surg. 2008;121(1):37–49.CrossRefGoogle Scholar
  45. 45.
    Ikeguchi R, Sacks JM, Unadkat JV, Solari M, Horibe EK, Thomson AW, et al. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression. Transplantation. 2008;85(2):237–46.CrossRefGoogle Scholar
  46. 46.
    Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4(5):267–74.Google Scholar
  47. 47.
    Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.CrossRefGoogle Scholar
  48. 48.
    Bieback K, Kern S, Kluter H, Eichler H. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625–34.CrossRefGoogle Scholar
  49. 49.
    Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003;101(9):3722–9.CrossRefGoogle Scholar
  50. 50.
    Zhao ZG, Xu W, Sun L, You Y, Li F, Li QB, et al. Immunomodulatory function of regulatory dendritic cells induced by mesenchymal stem cells. Immunol Investig. 2012;41(2):183–98.CrossRefGoogle Scholar
  51. 51.
    Zhang B, Liu R, Shi D, Liu X, Chen Y, Dou X, et al. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood. 2009;113(1):46–57.CrossRefGoogle Scholar
  52. 52.
    Kuo YR, Chen CC, Goto S, Lee IT, Huang CW, Tsai CC, et al. Modulation of immune response and T-cell regulation by donor adipose-derived stem cells in a rodent hind-limb allotransplant model. Plast Reconstr Surg. 2011;128(6):661e–72e.CrossRefGoogle Scholar
  53. 53.
    Murphy BD, Zuker RM, Borschel GH. Vascularized composite allotransplantation: an update on medical and surgical progress and remaining challenges. J Plast Reconstr Aesthet Surg. 2013;66(11):1449–55.CrossRefGoogle Scholar
  54. 54.
    Berli JU, Broyles JM, Lough D, Shridharani SM, Rochlin D, Cooney DS, et al. Current concepts and systematic review of vascularized composite allotransplantation of the abdominal wall. Clin Transpl. 2013;27(6):781–9.CrossRefGoogle Scholar
  55. 55.
    Carty MJ, Zuker R, Cavadas P, Pribaz JJ, Talbot SG, Pomahac B. The case for lower extremity allotransplantation. Plast Reconstr Surg. 2013;131(6):1272–7.CrossRefGoogle Scholar
  56. 56.
    Kermer C, Watzinger F, Oeckher M. Tongue transplantation: 10-month follow-up. Transplantation. 2008;85(4):654–5.CrossRefGoogle Scholar
  57. 57.
    Strome M, Stein J, Esclamado R, Hicks D, Lorenz RR, Braun W, et al. Laryngeal transplantation and 40-month follow-up. N Engl J Med. 2001;344(22):1676–9.CrossRefGoogle Scholar
  58. 58.
    Rose KG, Sesterhenn K, Wustrow F. Tracheal allotransplantation in man. Lancet. 1979;1(8113):433.CrossRefGoogle Scholar
  59. 59.
    Farwell DG, Birchall MA, Macchiarini P, Luu QC, de Mattos AM, Gallay BJ, et al. Laryngotracheal transplantation: technical modifications and functional outcomes. Laryngoscope. 2013;123(10):2502–8.Google Scholar
  60. 60.
    Diefenbeck M, Nerlich A, Schneeberger S, Wagner F, Hofmann GO. Allograft vasculopathy after allogeneic vascularized knee transplantation. Transpl Int. 2011;24(1):e1–5.CrossRefGoogle Scholar
  61. 61.
    Jiang HQ, Wang Y, Hu XB, Li YS, Li JS. Composite tissue allograft transplantation of cephalocervical skin flap and two ears. Plast Reconstr Surg. 2005;115(3):31e–5e. discussion 6e-7eCrossRefGoogle Scholar
  62. 62.
    Ozkan O, Akar ME, Erdogan O, Hadimioglu N. Uterus transplantation from a deceased donor. Fertil Steril. 2013;100(6):e41.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Yur-Ren Kuo
    • 1
    • 2
    • 3
  1. 1.Division of Plastic Surgery, Department of SurgeryKaohsiung Medical University HospitalKaohsiungTaiwan
  2. 2.Faculty of Medicine, College of MedicineKaohsiung Medical UniversityKaohsiungTaiwan
  3. 3.Department of Biological SciencesNational Sun Yat-sen UniversityKaohsiung CityTaiwan

Personalised recommendations